drugset / Trial / NCT05222412

Managed Access Programs for LNP023, Iptacopan

NCT05222412 ↗

Expanded access Available Novartis Pharmaceuticals

Summary

The purpose of this registration form is to list all Managed Access Programs (MAPs) related to LNP023, Iptacopan

Timeline

Start
—
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Background Iptacopan Small molecule — —